Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...
Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a five-year period and could ...
This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.
While the outcomes can be positive, Consumer Reports warns there are important considerations, especially for older adults, ...